BRIEF-Camurus Announces Expansion Of Lilly Collaboration

Eli Lilly
Cambiar Aggressive Value ETF

Eli Lilly

LLY

0.00

Cambiar Aggressive Value ETF

CAMX

0.00

June 1 (Reuters) - Camurus AB CAMX.ST:

  • CAMURUS ANNOUNCES EXPANSION OF LILLY COLLABORATION

  • ELI LILLY EXERCISES OPTION TO INCLUDE AMYLIN RECEPTOR AGONISTS IN CAMURUS COLLABORATION

  • AGREEMENT COVERS UP TO FOUR LILLY DRUG COMPOUNDS ACROSS THREE CLASSES

  • LILLY'S EXCLUSIVE GLOBAL RIGHTS TO FLUIDCRYSTAL TECHNOLOGY EXTENDED TO ADDITIONAL COMPOUND CLASS

  • ELIGIBLE FOR UP TO $290 MILLION UPFRONT, $580 MILLION SALES MILESTONES, PLUS ROYALTIES

  • OPTION EXERCISE TRIGGERS $5 MILLION INITIAL PAYMENT TO CAMURUS

Source text: ID:nWkr6FZcvJ

Further company coverage: CAMX.ST


This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.